Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  British Medical Bulletin

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/bmb/ldt034PMID 24200742
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulatory considerations in production of a cell therapy medicinal product in Europe to clinical research

  2014cited by this paper
• Stem Cell Models for Drug Discovery and Toxicology Studies

  2013cited by this paper
• Current status of registry of vaccine clinical trials conducted by Korean investigators in ClinicalTrials.gov, database of US National Institutes of Health

  2013cited by this paper
• Stem cells cruise to clinic

  2013cited by this paper
• Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.

  2013cited by this paper
• Japan’s stimulus package showers science with cash

  2013cited by this paper
• Book Review: Fundamentals of Clinical Trials. 4th ed.

  2013cited by this paper
• Autologous bone marrow-derived stem cell therapy in heart disease: discrepancies and contradictions.

  2013cited by this paper
• Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types.

  2012cited by this paper
• Embryonic stem cell trials for macular degeneration: a preliminary report.

  2012cited by this paper
• Precision manufacturing for clinical-quality regenerative medicines

  2012cited by this paper
• No factor left behind: generation of transgene-free induced pluripotent stem cells.

  2012cited by this paper
• Clinical development of advanced therapy medicinal products in Europe: evidence that regulators must be proactive.

  2012cited by this paper
• Cardiac regeneration.

  2012cited by this paper
• Cancer stem cells: impact, heterogeneity, and uncertainty.

  2012cited by this paper
• Human embryonic stem cells: early hints on safety and efficacy.

  2012cited by this paper
• Towards regenerative therapy for cardiac disease.

  2012cited by this paper
• Cellular Therapy Wave Finally Cresting

  2012cited by this paper
• Pluripotente Stammzellen zur Zellersatztherapie des Diabetes mellitus

  2012cited by this paper
• Fundamentals of Clinical Trials

  2012cited by this paper
• Induced pluripotent stem cells: opportunities and challenges

  2011cited by this paper
• [Gene therapy and rare diseases].

  2011cited by this paper
• Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine.

  2011cited by this paper
• DePICTing p53 activation: a new nucleolar link to cancer.

  2011cited by this paper
• Cardiac cell therapy: lessons from clinical trials.

  2011cited by this paper
• Challenges in Using Stem Cells for Cardiac Repair

  2010cited by this paper
• Cells as biologics for cardiac repair in ischaemic heart failure

  2010cited by this paper
• Cultivating regenerative medicine innovation in China.

  2010cited by this paper
• Environmental monitoring programme in the cell therapy facility of a research centre: preliminary investigation.

  2010cited by this paper
• Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back.

  2010cited by this paper
• Regenerative medicine: the emergence of an industry

  2010cited by this paper
• CAT – The new committee for advanced therapies at the European Medicines Agency

  2010cited by this paper
• Scalable pluripotent stem cell culture

  2010cited by this paper
• Celebration and Concern Over U.S. Trial of Embryonic Stem Cells

  2009cited by this paper
• Derivation of Functional Retinal Pigmented Epithelium from Induced Pluripotent Stem Cells

  2009cited by this paper
• Engineering microenvironments for embryonic stem cell differentiation to cardiomyocytes.

  2009cited by this paper
• Phase 0 trials: a platform for drug development?

  2009cited by this paper
• Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells.

  2009cited by this paper
• Cardiac cell repair therapy: a clinical perspective.

  2009cited by this paper
• Innovation in the culture and derivation of pluripotent human stem cells.

  2008cited by this paper
• A brief definition of regenerative medicine.

  2008cited by this paper
• Cell therapies: realizing the potential of this new dimension to medical therapeutics

  2008cited by this paper
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• Editorial: Advancing Tissue Engineering and Regenerative Medicine

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Bioprocessing of embryonic stem cells for drug discovery.

  2007cited by this paper
• Cardiac regeneration.

  2006cited by this paper
• FDA regulation of stem-cell-based therapies.

  2006cited by this paper
• Transcoronary transplantation of progenitor cells after myocardial infarction.

  2006cited by this paper
• Bringing safe and effective cell therapies to the bedside

  2005cited by this paper
• Embryonic stem cell lines derived from human blastocysts.

  1998cited by this paper
• Fundamentals of Clinical Trials

  1982cited by this paper
• Immunological reconstitution of sex-linked lymphopenic immunological deficiency.

  1968cited by this paper
• Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome.

  1968cited by this paper
• Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy.

  1957cited by this paper

• Cell-free therapeutics for non-healing wounds: role of MSC-derived exosomes in macrophage polarization, angiogenesis, and fibroblast-mediated ECM remodeling-bridging preclinical insights to clinical translation.

  2026cites this paper
• Application of neural stem cells in the treatment of intracerebral hemorrhage: a systematic review

  2025cites this paper
• Characteristics of Parthenogenetic Stem Cells and Their Potential Treatment Strategy for Central Nervous System Diseases

  2025cites this paper
• Current Status of Research on Nanomaterials Combined with Mesenchymal Stem Cells for the Treatment of Ischemic Stroke

  2024cites this paper
• Experience Of Atychiphobia And Its Impact On University Students

  2023cites this paper
• The Wisdom in Teeth: Neuronal Differentiation of Dental Pulp Cells

  2023cites this paper
• Resveratrol maintain Human Iliac Bone Marrow Mesenchymal Stem Cells Stemness through Sirtuin 1 Mediated Regulation of SRY-Box Transcription Factor 2: an in vitro and in silico study

  2022cites this paper
• Neonatal injury models: integral tools to decipher the molecular basis of cardiac regeneration

  2022cites this paper
• Recent Stem Cell Research on Hemorrhagic Stroke : An Update

  2022cites this paper
• Stem Cell Therapy and Regenerative Medicine in Autoimmune Diseases

  2021cites this paper
• Stem Cells in Regenerative Medicine: Clinical Trials

  2021cites this paper
• In Vitro Culturing of Adult Stem Cells: The Importance of Serum and Atmospheric Oxygen.

  2021cites this paper
• Stem cells technology as a platform for generating reproductive system organoids and treatment of infertility‐related diseases

  2021cites this paper
• Cryobanking of human distal lung epithelial cells for preservation of their phenotypic and functional characteristics

  2021cites this paper
• GMP-grade neural progenitor derivation and differentiation from clinical-grade human embryonic stem cells

  2020cites this paper
• Mesenchymal stem cells in neurodegenerative diseases: Opinion review on ethical dilemmas.

  2020cites this paper
• Mesenchymal stem cells prolong survival and prevent lethal complications in a porcine model of fulminant liver failure

  2019cites this paper
• Immunomodulatory potential of mesenchymal stem cell role in diseases and therapies: A bioengineering prospective

  2019cites this paper
• Expanded skeletal stem and progenitor cells promote and participate in induced bone regeneration at subcritical BMP-2 dose.

  2019cites this paper
• Ethics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials.

  2019cites this paper
• Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model

  2019cites this paper
• Recent Advances in Engineered Stem Cell-Derived Cell Sheets for Tissue Regeneration

  2019cites this paper
• Human induced pluripotent stem cells in regenerative medicine

  2019cites this paper
• The Influence of Cell Source and Donor Age on the Tenogenic Potential and Chemokine Secretion of Human Mesenchymal Stromal Cells

  2019cites this paper
• The impact of transposable element activity on therapeutically relevant human stem cells

  2019cites this paper
• Live Cell Imaging of Chromosome Segregation During Mitosis.

  2018cites this paper
• Cell Culture Bioprocess Technology: Biologics and Beyond

  2018cites this paper
• Non-invasive cell tracking of SPIO labeled cells in an intrinsic regenerative environment: The axolotl limb

  2018cites this paper
• Growth Behavior of Human Adipose Tissue-Derived Stromal/Stem Cells at Small Scale: Numerical and Experimental Investigations

  2018cites this paper
• Designer human tissue: coming to a lab near you

  2018cites this paper
• Development and characterisation of a cytokine supplemented serum free medium formulation for bone marrow derived mesenchymal stromal cells

  2018influential citation
• Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation

  2018cites this paper
• Isolation, Culture, and Functional Characterization of Human Embryonic Stem Cells: Current Trends and Challenges

  2018cites this paper
• Controlled delivery of icariin on small intestine submucosa for bone tissue engineering.

  2017cites this paper
• Tissue regeneration: The crosstalk between mesenchymal stem cells and immune response.

  2017cites this paper
• Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations

  2017cites this paper
• Three-Dimensional Human Cardiac Tissue Engineered by Centrifugation of Stacked Cell Sheets and Cross-Sectional Observation of Its Synchronous Beatings by Optical Coherence Tomography

  2017cites this paper
• Prospects of Pluripotent and Adult Stem Cells for Rare Diseases.

  2017cites this paper
• Stem Cells in Regenerative Medicine: Prospects and Pitfalls

  2017cites this paper
• Real-time quantitation of internal metabolic activity of three-dimensional engineered tissues using an oxygen microelectrode and optical coherence tomography.

  2017cites this paper
• Consideration of Biological Sex in Translating Regenerative Stem Cell Therapies

  2017cites this paper
• The Use of Technetium-99m for Intravital Tracing of Transplanted Multipotent Stromal Cells

  2016cites this paper
• Enrichment and Separation Technologies for Stem Cell-Based Therapies

  2016cites this paper
• Human Embryonic Stem Cell Research vs. Alternative Stem Cell Research: Is there a compromise?

  2016cites this paper
• Evidence and Access to Biomedical Interventions: The Case of Stem Cell Treatments.

  2016cites this paper
• Inhibition of IL-1R1/MyD88 signalling promotes mesenchymal stem cell-driven tissue regeneration

  2016cites this paper
• Challenging Regeneration to Transform Medicine

  2016cites this paper
• Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson’s Disease

  2016cites this paper
• Pluripotent stem cells progressing to the clinic

  2016cites this paper
• Title Inhibition of IL-1 R 1 / MyD 88 signalling promotes mesenchymalstem cell-driven tissue regeneration

  2016cites this paper
• Adapting Preclinical Benchmarks for First‐in‐Human Trials of Human Embryonic Stem Cell‐Based Therapies

  2016cites this paper
• The tumorigenic potential of pluripotent stem cells: What can we do to minimize it?

  2016cites this paper
• Extracellular Matrix-mediated Lung Epithelial Cell Differentiation

  2016cites this paper
• Stem Cell Therapies for Ischemic Cardiovascular Diseases

  2015cites this paper
• Stem Cell Therapies in Clinical Trials: Progress and Challenges.

  2015cites this paper
• Induction of Functional Hepatocyte-Like Cells by Overexpression of FOXA3 and HNF4α in Rat Bone Marrow Mesenchymal Stem Cells

  2015cites this paper
• Extracellular matrix-inspired growth factor delivery systems for bone regeneration.

  2015cites this paper
• Landscape of current and emerging cell therapy clinical trials in the UK: current status, comparison to global trends and future perspectives.

  2015cites this paper
• Human embryonic stem cell cultivation: historical perspective and evolution of xeno-free culture systems

  2015cites this paper
• The ethics of bringing Regenerative Medicine to patients: the example of orthopedics

  2015cites this paper
• Dextran-coated fluorapatite crystals doped with Yb3+/Ho3+ for labeling and tracking chondrogenic differentiation of bone marrow mesenchymal stem cells in vitro and in vivo.

  2015cites this paper
• Rapid fabrication system for three-dimensional tissues using cell sheet engineering and centrifugation.

  2015cites this paper
• Stem Cell Therapy: Are we Ready to use it?

  2014cites this paper
• Disturbed angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery disease and diabetes mellitus type 2

  2014cites this paper
• Modalities to Improve Cord Blood Engraftment

  2014cites this paper
• Cell-based therapy approaches: the hope for incurable diseases.

  2014cites this paper
• From production to patient: challenges and approaches for delivering cell therapies

  2014cites this paper
• Mass Production of Mesenchymal Stem Cells — Impact of Bioreactor Design and Flow Conditions on Proliferation and Differentiation

  2014cites this paper